5,497 Shares in LivaNova PLC (LIVN) Acquired by Invictus RG

Invictus RG acquired a new position in LivaNova PLC (NASDAQ:LIVN) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 5,497 shares of the company’s stock, valued at approximately $385,000.

Other hedge funds also recently bought and sold shares of the company. Airain ltd acquired a new stake in LivaNova during the 2nd quarter worth $1,449,000. Virginia Retirement Systems ET AL acquired a new stake in LivaNova during the 2nd quarter worth $2,277,000. Redmile Group LLC acquired a new stake in LivaNova during the 2nd quarter worth $12,978,000. Hosking Partners LLP grew its holdings in LivaNova by 1.6% during the 2nd quarter. Hosking Partners LLP now owns 188,518 shares of the company’s stock worth $11,539,000 after acquiring an additional 3,048 shares during the period. Finally, Russell Investments Group Ltd. acquired a new stake in LivaNova during the 2nd quarter worth $957,000. Hedge funds and other institutional investors own 86.07% of the company’s stock.

A number of analysts have commented on LIVN shares. Jefferies Group started coverage on shares of LivaNova in a report on Friday, September 8th. They set a “buy” rating and a $76.00 target price for the company. Needham & Company LLC raised shares of LivaNova from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a report on Friday, September 15th. ValuEngine raised shares of LivaNova from a “hold” rating to a “buy” rating in a report on Thursday, November 2nd. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $75.00 target price on shares of LivaNova in a report on Tuesday, September 12th. Finally, WBB Securities lowered shares of LivaNova from a “hold” rating to a “sell” rating and set a $50.00 target price for the company. in a report on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $79.71.

LivaNova PLC (NASDAQ LIVN) opened at $83.64 on Wednesday. LivaNova PLC has a fifty-two week low of $44.58 and a fifty-two week high of $88.56. The stock has a market cap of $3,989.02, a price-to-earnings ratio of 23.84, a PEG ratio of 2.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.03 and a quick ratio of 1.42.

LivaNova (NASDAQ:LIVN) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.17. LivaNova had a net margin of 4.63% and a return on equity of 9.33%. The company had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. During the same quarter in the previous year, the business earned $0.78 EPS. The firm’s revenue was up 4.9% on a year-over-year basis. sell-side analysts expect that LivaNova PLC will post 3.33 earnings per share for the current fiscal year.

In related news, Director Alfred J. Novak sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total value of $171,540.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $68.55, for a total transaction of $68,550.00. Following the completion of the transaction, the director now directly owns 57,296 shares of the company’s stock, valued at $3,927,640.80. The disclosure for this sale can be found here. Insiders sold a total of 6,830 shares of company stock valued at $557,100 in the last three months. 0.28% of the stock is owned by company insiders.

WARNING: This piece was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://ledgergazette.com/2017/12/06/5497-shares-in-livanova-plc-livn-acquired-by-invictus-rg.html.

About LivaNova

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply